Aptissen
Company specialized in the research, development and commercialization of biopolymer-based medical devices.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
N/A | Seed | ||
| Total Funding | 000k | ||
Related Content
Aptissen, founded in Switzerland in 2013, specializes in orthobiologic solutions aimed at treating joint disorders. The company focuses on developing innovative products that improve musculoskeletal health, catering primarily to patients suffering from conditions like osteoarthritis. Operating in the healthcare and medical devices market, Aptissen serves both healthcare professionals and patients. Its business model revolves around the research, development, and commercialization of medical products, generating revenue through product sales and partnerships with healthcare providers. The company emphasizes quality and patient well-being, ensuring that its solutions are both effective and reliable.
Keywords: orthobiologic, joint disorders, musculoskeletal health, osteoarthritis, healthcare, medical devices, innovation, patient well-being, product sales, partnerships.